OTC Markets OTCPK - Delayed Quote USD

CYduct Diagnostics, Inc. (CYDX)

0.2021

0.0000

(0.00%)

At close: April 18 at 4:00:00 PM EDT

Groundbreaking Study on Risk Assessment of Breast Cancer Aims to Revolutionize Diagnosis and Treatment

WESTPORT, CT / ACCESS Newswire / April 9, 2025 / CYduct Diagnostics, Inc. (OTCPK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of breast cancer risk assessment test and diagnostic ...

ACCESS Newswire 9 days ago

CYDX
0.00%
CYduct Diagnostics Announces Participation in The Reg A & Crowdfunding Conference

Westport, Connecticut--(Newsfile Corp. - May 22, 2024) - CYduct Diagnostics (OTC Pink: CYDX), CYductDX is a disruptive clinical-stage diagnostic company led by an experienced team of senior executives and scientists focused on proprietary technologies for the early assessment and detection of Breast Cancer., will be attending The Reg A & Crowdfunding Conference, which will take place on June 20 at the Westchester Country Club in Rye, New York. Dom Gatto: President/CEO ...

Newsfile 10 months ago

CYDX
0.00%
Cyduct Diagnostics To Participate at the 10th Annual Yale Innovation Summit

Yale Innovation Summit, May 29-30, New Haven, CT. WESTPORT, CT / ACCESSWIRE / May 16, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", "CYductDX", or the "Company"), an innovator in precision breast health enabled by non-invasive intraductal ...

ACCESS Newswire 10 months ago

CYDX
0.00%

Performance Overview

Return	CYDX	S&P 500 (^GSPC)
YTD	+32.87%	-10.18%
1-Year	-32.63%	+5.42%
3-Year	-71.93%	+20.29%